Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Case

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Comprehensive Psychiatry|April 24, 2012
Health-related quality of life as measured by the child health questionnaire in adolescents with bipolar disorder treated with olanzapineBrian T Olsen, Stephen J Ganocy, Samantha M Bitter, et al.
Journal of Biopharmaceutical Statistics|April 13, 2017
Statistical properties of continuous composite scales and implications for drug developmentHong Liu-Seifert, Scott Andersen, Michael Case, et al.
Cephalalgia : an International Journal of Headache|August 22, 2019
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)Jan Lewis Brandes, Suzanne Klise, John H Krege, et al.
The Journal of Clinical Psychiatry|March 6, 2007
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorderMichael E Thase, Sara A Corya, Olawale Osuntokun, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2015
Empirically Defining Trajectories of Late-Life Cognitive and Functional DeclineHelen Hochstetler, Paula T Trzepacz, Shufang Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 29, 2015
Florbetapir positron emission tomography and cerebrospinal fluid biomarkersAnn Hake, Paula T Trzepacz, Shufang Wang, et al.
The Journal of Clinical Psychiatry|March 17, 2009
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depressionMadhukar H Trivedi, Michael E Thase, Olawale Osuntokun, et al.
The Journal of Clinical Psychiatry|May 14, 2005
Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depressionPaul E Keck, Sara A Corya, Lori L Altshuler, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 5, 2022
Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementiaDiana Otero Svaldi, Ixavier A Higgins, Karen C Holdridge, et al.
Psychiatry Research|December 21, 2010
Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosisVirginia L Stauffer, Michael Case, Bruce J Kinon, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Comprehensive Psychiatry|April 24, 2012
Health-related quality of life as measured by the child health questionnaire in adolescents with bipolar disorder treated with olanzapineBrian T Olsen, Stephen J Ganocy, Samantha M Bitter, et al.
Journal of Biopharmaceutical Statistics|April 13, 2017
Statistical properties of continuous composite scales and implications for drug developmentHong Liu-Seifert, Scott Andersen, Michael Case, et al.
Cephalalgia : an International Journal of Headache|August 22, 2019
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)Jan Lewis Brandes, Suzanne Klise, John H Krege, et al.
The Journal of Clinical Psychiatry|March 6, 2007
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorderMichael E Thase, Sara A Corya, Olawale Osuntokun, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2015
Empirically Defining Trajectories of Late-Life Cognitive and Functional DeclineHelen Hochstetler, Paula T Trzepacz, Shufang Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 29, 2015
Florbetapir positron emission tomography and cerebrospinal fluid biomarkersAnn Hake, Paula T Trzepacz, Shufang Wang, et al.
The Journal of Clinical Psychiatry|March 17, 2009
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depressionMadhukar H Trivedi, Michael E Thase, Olawale Osuntokun, et al.
The Journal of Clinical Psychiatry|May 14, 2005
Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depressionPaul E Keck, Sara A Corya, Lori L Altshuler, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 5, 2022
Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementiaDiana Otero Svaldi, Ixavier A Higgins, Karen C Holdridge, et al.
Psychiatry Research|December 21, 2010
Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosisVirginia L Stauffer, Michael Case, Bruce J Kinon, et al.
Pageof 4